NE DEMEK?

The efficacy of type 5 phosphodiesterase inhibitors (PDE5i) saf been verified by countless studies, and indeed these drugs have been included bey the first-line treatment for the management of erectile dysfunction (ED).1 It is therefore unsurprising that the general population özgü heard about these drugs, including patients with a very limited a

Based on current evidence, it birey be assumed that the copyright market is flourishing because of an ever-increasing demand, largely supported by the lacking awareness of the health risks and sub-standard efficacy of these products.133 Bey a consequence, strategies acting to reduce demand, mostly by raising awareness of the potential issues, could